Cerebral (Fatal) Malaria-Pipeline Review, H2 2016

Cerebral (Fatal) Malaria-Pipeline Review, H2 2016


  • Products Id :- GMDHC8915IDB
  • |
  • Pages: 37
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Cerebral (Fatal) Malaria-Pipeline Review, H2 2016

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cerebral (Fatal) Malaria-Pipeline Review, H2 2016, provides an overview of the Cerebral (Fatal) Malaria (Infectious Disease) pipeline landscape.

Cerebral malaria is the most dangerous and life-threatening form of malaria that affects the brain. It is caused by plasmodium falciparum, a protozoan parasite. Plasmodium gets transmitted to human via infected mosquito bites.Symptoms include fever, head ache, muscle pain, low blood pressure, coma and convulsions. Treatment includes antimalarial, antiseizure and anti inflammatory medications.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Cerebral (Fatal) Malaria-Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Cerebral (Fatal) Malaria (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Cerebral (Fatal) Malaria (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Cerebral (Fatal) Malaria and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Preclinical and Discovery stages are 4 and 1 respectively. Similarly, the Universities portfolio in Phase I and Preclinical stages comprises 1 and 1 molecules, respectively.

Cerebral (Fatal) Malaria (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

The pipeline guide provides a snapshot of the global therapeutic landscape of Cerebral (Fatal) Malaria (Infectious Disease).

The pipeline guide reviews pipeline therapeutics for Cerebral (Fatal) Malaria (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Cerebral (Fatal) Malaria (Infectious Disease) therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Cerebral (Fatal) Malaria (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

The pipeline guide reviews latest news related to pipeline therapeutics for Cerebral (Fatal) Malaria (Infectious Disease)

Reasons to Buy

Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

Find and recognize significant and varied types of therapeutics under development for Cerebral (Fatal) Malaria (Infectious Disease).

Classify potential new clients or partners in the target demographic.

Develop tactical initiatives by understanding the focus areas of leading companies.

Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

Formulate corrective measures for pipeline projects by understanding Cerebral (Fatal) Malaria (Infectious Disease) pipeline depth and focus of Indication therapeutics.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Introduction 5

Global Markets Direct Report Coverage 5

Cerebral (Fatal) Malaria Overview 6

Therapeutics Development 7

Pipeline Products for Cerebral (Fatal) Malaria-Overview 7

Pipeline Products for Cerebral (Fatal) Malaria-Comparative Analysis 8

Cerebral (Fatal) Malaria-Therapeutics under Development by Companies 9

Cerebral (Fatal) Malaria-Therapeutics under Investigation by Universities/Institutes 10

Cerebral (Fatal) Malaria-Pipeline Products Glance 11

Clinical Stage Products 11

Early Stage Products 12

Cerebral (Fatal) Malaria-Products under Development by Companies 13

Cerebral (Fatal) Malaria-Products under Investigation by Universities/Institutes 14

Cerebral (Fatal) Malaria-Companies Involved in Therapeutics Development 15

Callaghan Innovation Research Ltd 15

Eisai Co Ltd 16

Lipocure Ltd 17

Cerebral (Fatal) Malaria-Therapeutics Assessment 18

Assessment by Monotherapy Products 18

Assessment by Target 19

Assessment by Mechanism of Action 21

Assessment by Route of Administration 23

Assessment by Molecule Type 25

Drug Profiles 27

E-6446-Drug Profile 27

Product Description 27

Mechanism Of Action 27

R&D Progress 27

malaria vaccine-Drug Profile 28

Product Description 28

Mechanism Of Action 28

R&D Progress 28

malaria vaccine 6-Drug Profile 29

Product Description 29

Mechanism Of Action 29

R&D Progress 29

methylprednisolone sodium phosphate-Drug Profile 30

Product Description 30

Mechanism Of Action 30

R&D Progress 30

neuregulin-1-Drug Profile 31

Product Description 31

Mechanism Of Action 31

R&D Progress 31

RRX-001-Drug Profile 32

Product Description 32

Mechanism Of Action 32

R&D Progress 32

Small Molecule to Inhibit Hypoxanthine Phosphoribosyltransferase for Malaria-Drug Profile 34

Product Description 34

Mechanism Of Action 34

R&D Progress 34

Cerebral (Fatal) Malaria-Dormant Projects 35

Appendix 36

Methodology 36

Coverage 36

Secondary Research 36

Primary Research 36

Expert Panel Validation 36

Contact Us 36

Disclaimer 37

List of Figures

Number of Products under Development for Cerebral (Fatal) Malaria, H2 2016 7

Number of Products under Development for Cerebral (Fatal) Malaria-Comparative Analysis, H2 2016 8

Number of Products under Development by Companies, H2 2016 9

Number of Products under Investigation by Universities/Institutes, H2 2016 10

Comparative Analysis by Early Stage Products, H2 2016 12

Assessment by Monotherapy Products, H2 2016 18

Number of Products by Targets, H2 2016 19

Number of Products by Stage and Targets, H2 2016 19

Number of Products by Mechanism of Actions, H2 2016 21

Number of Products by Stage and Mechanism of Actions, H2 2016 21

Number of Products by Routes of Administration, H2 2016 23

Number of Products by Stage and Routes of Administration, H2 2016 23

Number of Products by Molecule Types, H2 2016 25

Number of Products by Stage and Molecule Types, H2 2016 25

List of Tables

Number of Products under Development for Cerebral (Fatal) Malaria, H2 2016 7

Number of Products under Development for Cerebral (Fatal) Malaria-Comparative Analysis, H2 2016 8

Number of Products under Development by Companies, H2 2016 9

Number of Products under Investigation by Universities/Institutes, H2 2016 10

Comparative Analysis by Clinical Stage Development, H2 2016 11

Comparative Analysis by Early Stage Development, H2 2016 12

Products under Development by Companies, H2 2016 13

Products under Investigation by Universities/Institutes, H2 2016 14

Cerebral (Fatal) Malaria-Pipeline by Callaghan Innovation Research Ltd, H2 2016 15

Cerebral (Fatal) Malaria-Pipeline by Eisai Co Ltd, H2 2016 16

Cerebral (Fatal) Malaria-Pipeline by Lipocure Ltd, H2 2016 17

Assessment by Monotherapy Products, H2 2016 18

Number of Products by Stage and Target, H2 2016 20

Number of Products by Stage and Mechanism of Action, H2 2016 22

Number of Products by Stage and Route of Administration, H2 2016 24

Number of Products by Stage and Molecule Type, H2 2016 26

Cerebral (Fatal) Malaria-Dormant Projects, H2 2016 35

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Callaghan Innovation Research Ltd, Eisai Co Ltd, Lipocure Ltd

Cerebral (Fatal) Malaria Therapeutic Products under Development, Key Players in Cerebral (Fatal) Malaria Therapeutics, Cerebral (Fatal) Malaria Pipeline Overview, Cerebral (Fatal) Malaria Pipeline, Cerebral (Fatal) Malaria Pipeline Assessment

select a license

Single User License
USD 2000 INR 129560
Site License
USD 4000 INR 259120
Corporate User License
USD 6000 INR 388680

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com